Treatment Delay and Management Challenges in Patients with Cervical Cancer at a Tertiary Care Facility

Abstract

Background: Cervical cancer is a major public health issue, particularly in low and middle income countries with common delayed diagnosis and treatment. Limited screening access, inadequate healthcare infrastructure and socioeconomic barriers lead to late presentation and poor outcomes. Timely diagnosis and treatment are critical for improving survival. This study assessed treatment delay and management challenges among cervical cancer patients at a tertiary care facility in Bangladesh.

Methods: This retrospective observational study was conducted in the Department of Gynecological Oncology at Bangladesh Medical University, Dhaka, from January to December 2025. A total of 511 patients with histopathologically confirmed cervical cancer were included. Sociodemographic characteristics, clinical features, treatment modalities and delay patterns were extracted from hospital records using a structured tool. Data were analyzed using SPSS version 25.0.

Results: Most patients were aged 40-49 years (31.7%) and the majority resided in rural areas (62.2%). Squamous cell carcinoma was the predominant type (83.6%). More than half were diagnosed at advanced stages (Stage III–IV). Concurrent chemoradiotherapy was the most common treatment (55.8%). A substantial proportion delayed seeking consultation for over three months (44.2%). Additionally, 42.9% experienced treatment delays exceeding 60 days. Rural residence, lower education, advanced stage at diagnosis and visiting multiple facilities before referral were significantly associated with delayed treatment.

Conclusion: Treatment delays are a significant challenge in cervical cancer management. Addressing patient awareness, referral pathways and healthcare infrastructure is essential to improve timely access to cancer treatment.